T3 potentiates  insulin signaling and improves  insulin sensitivity.
In addition,  T3 lowers  blood glucose in a model of type 2 diabetes.
TRalpha P398H mutation is associated with insulin resistance.
Circulating T(1)AM is produced from thyroid hormones and is found to be increased in diabetic patients.
